Padeliporfin

Posted on 19th November 2020 by Karen Jennison

Grey

Brand Name(s):TOOKAD

Indication:Cancer -adenocarcinoma of the prostate

Rationale:1

Considered:Aug-18

Review Date:Jan-24

Comments:
NICE TA546
Padeliporfifin for untreated localised
prostate cancer
Nov 18